newsfilter
← Latest News
PR Newswire·

Neuralstem Reports Second Quarter 2019 Fiscal Results

Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and...